Are we treating osteoporotic fractures of the hip adequately? A Middle Eastern cohort study
- 138 Downloads
Fragility hip fractures treated in a center in the Middle East were retrospectively studied for adequacy of osteoporosis management. Of the 318 patients treated, over 70% did not have a structured investigation and about 30% did not receive any therapeutic supplements. Our series showed a preventable 8.8% secondary fracture rate.
To study the adequacy of evaluation and treatment of osteoporosis after fragility fractures of the hip. The study also attempts to estimate the prevalence of secondary fractures after the original injury.
This is a retrospective evaluation of the electronic database to search all the admissions for fractures of the hip in patients over 50 years at a tertiary care Trauma and Orthopaedic center in the Sultanate of Oman. The study period was defined as October 2010 to December 2015. Their case records, BMD reports, and laboratory data were analyzed. Pharmacological interventions and the documented compliance with such therapy were also recorded.
Over the study period, 318 fragility fractures of the hip were treated. Of these, 233 (73.3%) did not receive a DEXA scan and 94% did not have their vitamin D3 (vit D) tested. About 29.9% percent cases did not receive any nutritional supplement or therapeutic intervention though diagnosed as fragility fracture. Twenty-eight patients (8.8%) reported for secondary fractures of the hip. Of these, 86% was initiated on supplement after their index fracture though 78.6% had not had a BMD study.
Less than 27% patients receive BMD test following fragility fracture of the hip and only 6% a vit D3 assay. Secondary fractures of the hip tend to occur in approximately 9% of the cases in Oman; this seems to occur equally in patients who have had as well as not had any calcium and vit D supplements after the index injury.
KeywordsSecondary fracture Hip fracture Fragility fracture of hip Osteoporosis in the Middle East Vitamin D deficiency
Compliance with ethical standards
Conflict of interest
- 1.Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E (2012) ASBMR task force on secondary fracture prevention. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27(10):2039–2046. https://doi.org/10.1002/jbmr.1698 CrossRefPubMedGoogle Scholar
- 3.Javaid MK, Kyer C, Mitchell PJ, Chana J, Moss C, Edwards MH, McLellan AR, Stenmark J, Pierroz DD, Schneider MC, Kanis JA, Akesson K, Cooper C, IOF Fracture Working Group; EXCO (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool. Osteoporos Int 26(11):2573–2578. https://doi.org/10.1007/s00198-015-3192-0 CrossRefPubMedGoogle Scholar
- 4.Drew S, Judge A, May C, Farmer A, Cooper C, Javaid MK, Gooberman-Hill R, REFReSH study group (2015) Implementation of secondary fracture prevention services after hip fracture: a qualitative study using extended Normalization Process Theory. Implement Sci 10(1):57. https://doi.org/10.1186/s13012-015-0243-z CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, AR ML, Mitchell PJ, Sale JE, Wahl DA, IOF CSA Fracture Working Group (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22(7):2051–2065. https://doi.org/10.1007/s00198-011-1642-x CrossRefPubMedGoogle Scholar
- 6.Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C, IOF Fracture Working Group (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24(8):2135–2152. https://doi.org/10.1007/s00198-013-2348-z CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Mettyas T, Carpenter C (2013) Secondary prevention of osteoporosis in non-neck of femur fragility fractures: is it value for money? A retrospective, prospective and cross-sectional cohort study. J Orthop Surg Res 8(1):44. https://doi.org/10.1186/1749-799X-8-44 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Petrella RJ, Jones TJ (2006) Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Fam Pract 7(1). https://doi.org/10.1186/1471-2296-7-31
- 16.Kamel HK (2005) Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough? J Clin Rheumatol 11(2):68–71. https://doi.org/10.1097/01.rhu.0000158545.26370.5c CrossRefPubMedGoogle Scholar
- 18.Drew S, Sheard S, Chana J, Cooper C, Javaid MK, Judge A, REFReSH study group (2014) Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England. Osteoporos Int 25(10):2427–2433. https://doi.org/10.1007/s00198-014-2775-5 CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Hreybe H, Salamoun M, Badra M, Afeiche N, Baddoura O, Boulos S, Haidar R, Lakkis S, Musharrafieh R, Nsouli A, Taha A, Tayim A, El-Hajj Fuleihan G (2004) Hip fractures in Lebanese patients: determinants and prognosis. J Clin Densitom 7(4):368–375. https://doi.org/10.1385/JCD:7:4:368 CrossRefPubMedGoogle Scholar
- 24.Fuleihan GE. Stenmark J, Misteli L. (Eds). (2011). The Middle East and Africa regional Audit: epidemiology, costs & burden of osteoporosis in 2011. International Osteoporosis Foundation 102011–5000.Google Scholar
- 29.Mitchell P, Åkesson K, Chandran M, Cooper C, Ganda K, Schneider M (2016) Implementation of models of care for secondary osteoporotic fracture prevention and orthogeriatric models of care for osteoporotic hip fracture. Best Pract Res Clin Rheumatol 30(3):536–558. https://doi.org/10.1016/j.berh.2016.09.008 CrossRefPubMedGoogle Scholar
- 30.Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B, Eisman JA, Geusens PP, Brink PR (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96(4):e29. https://doi.org/10.2106/JBJS.L.00223 CrossRefPubMedGoogle Scholar
- 36.Nurmi-Lüthje I, Lüthje P, Kaukonen JP, Kataja M, Kuurne S, Naboulsi H, Karjalainen K (2009) Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Drugs Aging 26(5):409–421. https://doi.org/10.2165/00002512-200926050-00005 CrossRefPubMedGoogle Scholar
- 37.Nurmi-Lüthje I, Sund R, Juntunen M, Lüthje P (2011) Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland. J Bone Miner Res 26(8):1845–1853. https://doi.org/10.1002/jbmr.375 CrossRefPubMedGoogle Scholar